Texas Permanent School Fund boosted its position in shares of Masimo Corporation (NASDAQ:MASI) by 2.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,233 shares of the medical equipment provider’s stock after buying an additional 744 shares during the period. Texas Permanent School Fund owned about 0.06% of Masimo Corporation worth $3,030,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of MASI. JPMorgan Chase & Co. increased its position in shares of Masimo Corporation by 11.2% in the first quarter. JPMorgan Chase & Co. now owns 455,338 shares of the medical equipment provider’s stock worth $42,466,000 after buying an additional 45,833 shares during the period. Geode Capital Management LLC increased its stake in Masimo Corporation by 36.9% in the first quarter. Geode Capital Management LLC now owns 645,254 shares of the medical equipment provider’s stock valued at $60,175,000 after buying an additional 173,931 shares during the period. Swiss National Bank increased its stake in Masimo Corporation by 0.9% in the first quarter. Swiss National Bank now owns 77,800 shares of the medical equipment provider’s stock valued at $7,256,000 after buying an additional 700 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS bought a new stake in Masimo Corporation during the first quarter valued at about $1,223,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Masimo Corporation by 32.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,782 shares of the medical equipment provider’s stock valued at $166,000 after buying an additional 434 shares during the period. Hedge funds and other institutional investors own 84.39% of the company’s stock.

Shares of Masimo Corporation (NASDAQ:MASI) opened at 85.29 on Monday. Masimo Corporation has a 1-year low of $52.07 and a 1-year high of $104.71. The company has a market cap of $4.43 billion, a P/E ratio of 13.98 and a beta of 0.80. The stock’s 50 day moving average price is $93.60 and its 200 day moving average price is $89.40.

Masimo Corporation (NASDAQ:MASI) last announced its quarterly earnings data on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.71 by $0.12. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. The company had revenue of $192.90 million during the quarter, compared to analysts’ expectations of $189.03 million. During the same quarter last year, the company earned $0.57 EPS. Masimo Corporation’s revenue for the quarter was up 11.8% compared to the same quarter last year. Equities research analysts forecast that Masimo Corporation will post $2.78 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This news story was first reported by Daily Political and is owned by of Daily Political. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.dailypolitical.com/2017/08/07/texas-permanent-school-fund-purchases-744-shares-of-masimo-corporation-nasdaqmasi.html.

Several analysts have recently issued reports on the company. Roth Capital upped their price target on Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, July 19th. BidaskClub downgraded Masimo Corporation from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Zacks Investment Research upgraded Masimo Corporation from a “sell” rating to a “hold” rating in a research note on Tuesday, July 11th. Stifel Nicolaus assumed coverage on Masimo Corporation in a research note on Monday, July 10th. They set a “buy” rating and a $105.00 price target for the company. Finally, Wedbush reiterated an “outperform” rating and set a $112.00 price target on shares of Masimo Corporation in a research note on Monday, May 22nd. Five investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Masimo Corporation currently has a consensus rating of “Hold” and a consensus target price of $94.00.

In related news, insider Jon Coleman sold 25,000 shares of Masimo Corporation stock in a transaction dated Thursday, July 20th. The stock was sold at an average price of $97.50, for a total transaction of $2,437,500.00. Following the completion of the transaction, the insider now owns 32,201 shares in the company, valued at $3,139,597.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Rick Fishel sold 15,000 shares of Masimo Corporation stock in a transaction dated Friday, July 14th. The stock was sold at an average price of $94.85, for a total value of $1,422,750.00. Following the transaction, the insider now owns 35,022 shares of the company’s stock, valued at approximately $3,321,836.70. The disclosure for this sale can be found here. Insiders have sold 115,000 shares of company stock valued at $10,773,180 in the last quarter. 16.60% of the stock is currently owned by corporate insiders.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.